Your feedback is important! Please take a few minutes to complete this short survey. This information will help us develop programs most relevant to your needs.

Question Title

* 1. Contact Information

Question Title

* 2. Having participated in this program, how much do you agree with the following statements?
(1 = Strongly disagree; 5 = Strongly agree)

  1 2 3 4 5
I am confident in my ability to access information that will help me make an informed decision about treatment selection for my myeloma subtype.
I am confident in my ability to communicate my needs to my care team when considering treatment options.
I am aware that a clinical trial may be the best option for me, based on the specific disease subtype I have.
The content was easy to follow and understand.
I am interested in learning more about clinical trials.

Question Title

* 3. Rate your experience with our educational resources on the MMRF.org (1 = Very unsatisfied; 5 = Very satisfied; NA = Not applicable)

  1 2 3 4 5 N/A
MMRF Patient Toolkit
High-Impact Topic (HIT) videos
Fast Facts in Myeloma sheets
MMRF Myeloma Matters podcasts
The MMRF Patient Toolkit contains patient-friendly educational booklets that provide detailed information on several essential areas of multiple myeloma patient care.
The High-Impact Topic (HIT) videos use animations and narration to present information on various myeloma topics.
Fast Facts in Myeloma are one-page guides that contain images and patient-friendly answers to important questions about different aspects of having and managing multiple myeloma.
MMRF Myeloma Matters podcasts are moderated online discussions with patients that cover quality of life and other topics of importance to patients with multiple myeloma.

Question Title

Image

Question Title

* 4. If there are other topics you would be interested in learning about, or if you have any comments or suggestions about this (or future) MMRF patient activities or resources, please share them here.

Thank you for completing this survey. Your input will help us develop additional educational programs that address the needs of the myeloma community.

T